Aurobindo Pharma Limited
AUROPHARMA
Rang in Aktien
#2069
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Aktienkurs
$17.34
Marktkapitalisierung
$9.98B
Veränderung (1 Tag)
-3.08%
Veränderung (1 Jahr)
38.71%
Land
IN
Handel Aurobindo Pharma Limited (AUROPHARMA)
Kategorie
Healthcare
P/S-Verhältnis für Aurobindo Pharma Limited (AUROPHARMA)
P/S-Verhältnis zum October 2026 TTM: 2.77
Laut den neuesten Finanzberichten und dem Aktienkurs von Aurobindo Pharma Limited beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 2.77. Am Ende des Jahres 2024 lag das P/S-Verhältnis bei 2.25.
P/S-Verlauf für Aurobindo Pharma Limited von 2004 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 2.77 | 33.31% |
| 2025 | 2.08 | -7.36% |
| 2024 | 2.25 | 82.40% |
| 2023 | 1.23 | -26.44% |
| 2022 | 1.68 | -20.27% |
| 2021 | 2.10 | 97.49% |
| 2020 | 1.06 | -55.13% |
| 2019 | 2.37 | 10.73% |
| 2018 | 2.14 | -20.47% |
| 2017 | 2.69 | -15.48% |
| 2016 | 3.19 | 7.66% |
| 2015 | 2.96 | 59.79% |
| 2014 | 1.85 | 142.25% |
| 2013 | 0.77 | 0.21% |
| 2012 | 0.76 | -40.71% |
| 2011 | 1.29 | -11.40% |
| 2010 | 1.45 | 342.21% |
| 2009 | 0.33 | -48.77% |
| 2008 | 0.64 | -62.35% |
| 2007 | 1.70 | -24.28% |
| 2006 | 2.25 | 103.16% |
| 2005 | 1.11 | -7.07% |
| 2004 | 1.19 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | 154.53% |
IN
|
